ArticleInternational orthopaedics2016

A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head.

Yutaka Kuroda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.